Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other Operating Expenses: 2009-2025

Historic Other Operating Expenses for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to $100.9 million.

  • UNITED THERAPEUTICS's Other Operating Expenses rose 21.42% to $100.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $356.9 million, marking a year-over-year increase of 17.09%. This contributed to the annual value of $309.7 million for FY2024, which is 20.27% up from last year.
  • UNITED THERAPEUTICS's Other Operating Expenses amounted to $100.9 million in Q3 2025, which was up 15.18% from $87.6 million recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Other Operating Expenses registered a high of $140.2 million during Q1 2021, and its lowest value of $25.9 million during Q1 2022.
  • For the 3-year period, UNITED THERAPEUTICS's Other Operating Expenses averaged around $77.1 million, with its median value being $75.9 million (2024).
  • In the last 5 years, UNITED THERAPEUTICS's Other Operating Expenses plummeted by 82.12% in 2021 and then spiked by 115.82% in 2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Other Operating Expenses (Quarterly) stood at $34.6 million in 2021, then skyrocketed by 69.94% to $58.8 million in 2022, then rose by 20.75% to $71.0 million in 2023, then increased by 6.90% to $75.9 million in 2024, then climbed by 21.42% to $100.9 million in 2025.
  • Its Other Operating Expenses was $100.9 million in Q3 2025, compared to $87.6 million in Q2 2025 and $92.5 million in Q1 2025.